Novo Nordisk Makes $9 Billion Bid for Metsera, Topping Pfizer's Offer

Novo Nordisk offers $77.75/share for Metsera in $9B deal, beating Pfizer's bid. Two-step structure includes immediate $56.50 dividend + milestone payments.